ESR1 and breast cancer: The screening of 175 breast cancer patients showed that 55% of them were found to display the cytoplasmic ERα complex: these tumors were associated with AKT activation, either positivity or negativity of the expression of nuclear ERα and reduced survival following standard treatment, when compared to patients with no cytoplasmic ERα complex [301].